Drug Companies to Offer Cervical Vaccine at Cheaper Rates to Poor Nations

by Medindia Content Team on October 9, 2007 at 8:05 PM
Drug Companies to Offer Cervical Vaccine at Cheaper Rates to Poor Nations

Poorer countries might soon have an easy access to cervical cancer vaccine, for two companies that manufacture the vaccine have promised to provide it at a reduced cost to these countries.

Cervical cancer rates are going up as more women than ever are surviving into middle age in poor countries.


At a conference organised by the UN Development Fund for Women in Brussels, Belgium, last week, one of the companies, Merck, pledged to give enough vaccine to treat a million women in the poorest countries over the next five years.

A course of vaccine against the human papillomavirus (HPV), the cause of the majority of cases, is about 360 dollars in the US, reports New Scientist.

Out of the 250,000 women killed by cervical cancer annually, 80 per cent belong to poor nations. In developed countries, the screening to catch the cancer early has cut death rates.

The conference urged participants to develop more screening techniques in poor nations.

HPV is a sexually transmitted infection, and so the vaccine is targeted at young girls who are not yet sexually active.

Source: ANI
Font : A-A+



Recommended Readings

Latest Drug News

Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Apotransferrin's Potential in Early Stroke Therapy Revealed
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
Anti-cancer Drug Navitoclax Help Treat Lower Back Pain
The reduction of these senescent osteoclasts, possibly through the utilization of current medications, could present a novel approach in managing lower back pain.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Drug Companies to Offer Cervical Vaccine at Cheaper Rates to Poor Nations Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests